Saridine SRL
1.4 FTESaridine reported total assets of 67,962 € at the end of the 2025 financial year (annual accounts filed with the NBB on 09 Jul 2026), with 1.4 full-time equivalent.
The score of Saridine shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +36 % Total assets +148 % Headcount (avg FTE) -30 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Saridine's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Jul 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 12 Aug 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 01 Jul 2022
Saridine's financial analysis
- Solvency28.6%sector median: 47.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Saridine
Saridine's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0726.990.452
- VAT number
- BE0726990452
- Peppol
- Registered · 0208:0726990452 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 May 2019
- Registered office
- 9450 Haaltert
- Size
- Micro · 1.4 FTE
- Latest accounts
- 2025 · filed on 09 Jul 2026
- Activity
- Retail sale of corrective glasses, lenses and sunglasses (NACE 47742)
Saridine (SRL) has been based in Haaltert since 2019, active in: retail sale of corrective glasses, lenses and sunglasses. For 2025, it reports a net profit of 3,447 € and equity of 19,439 €; its revenue is not published. With 1.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 28.6%, below the median of its sector (47.4%).
Companies similar to Saridine
Companies in the same business, of comparable size and area, outside its group.
- Horloge Retail sale of medical and orthopaedic goods Anderlecht · balance sheet 71,701 €
- Optiek Nachtergaele Retail sale of medical and orthopaedic goods Ninove · balance sheet 70,769 €
- Optibex Retail sale of medical and orthopaedic goods Liège · balance sheet 67,923 €
- L'Autre Optique Retail sale of medical and orthopaedic goods Wemmel · balance sheet 68,628 €
- Optic & Retail sale of medical and orthopaedic goods Eupen · balance sheet 67,088 €
- Brillen JAN Serry Retail sale of medical and orthopaedic goods Torhout · balance sheet 65,547 €
- Ideal - Image Retail sale of medical and orthopaedic goods Rixensart · balance sheet 70,560 €
- Gabriel Optique Retail sale of medical and orthopaedic goods Trois-Ponts · balance sheet 70,815 €
Frequently asked questions about Saridine
What is the revenue of Saridine?
Saridine files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Saridine?
In Belgium, the VAT number is the company number prefixed with BE: BE0726990452 for Saridine, if the company is VAT-registered. Its company number (CBE) is 0726.990.452.
Where is the registered office of Saridine?
According to the CBE register, the registered office of Saridine is in 9450 Haaltert.
What is the equity of Saridine?
At the close of the 2025 financial year, the equity of Saridine amounts to 19,439 €, a solvency of 28.6% of total assets.
How many people work at Saridine?
1.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Saridine?
The register lists 2 active mandates at Saridine. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Saridine
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →